Alcon Pharmaceuticals

growth-positive

The article highlights recent research calls on Wall Street, focusing on upgrades and downgrades of various companies. HP Enterprise (HPE) was upgraded by Morgan Stanley to Overweight with a price target increase, indicating a positive outlook due to potential benefits from the Juniper acquisition. CoreWeave and Bio-Techne also received upgrades with increased price targets, suggesting undervaluation and growth potential. Conversely, companies like Instacart and Coty faced downgrades due to increased competition and weaker-than-expected results. The article provides insights into market perceptions and expectations for these companies.

growth-positive

Alcon Pharmaceuticals is acquiring Israeli healthtech company Belkin Vision, according to a report filed by BioLight to the Tel Aviv Stock Exchange. Belkin Vision, valued at up to $330 million, has developed a non-contact automated glaucoma laser therapy. The company has raised about $45 million to date, including grants from the European Union and the Israel Innovation Authority. All Belkin shares will be transferred to a wholly-owned subsidiary of Alcon, with BioLight to receive $9 million in cash immediately upon completion of the transaction, and an additional future compensation of up to $10.8 million, depending on meeting milestones.